Acadian Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $163M | Buy |
|
|||||
|
2025
Q2 | $143M | Buy |
|
|||||
|
2025
Q1 | $6.03M | Sell |
|
|||||
|
2024
Q4 | $8.52M | Sell |
|
|||||
|
2024
Q3 | $40.2M | Buy |
|
|||||
|
2024
Q2 | $897K | Sell |
|
|||||
|
2024
Q1 | $834K | Sell |
|
|||||
|
2023
Q4 | $1.77M | Sell |
|
|||||
|
2023
Q3 | $2.69M | Sell |
|
|||||
|
2023
Q2 | $9.03M | Buy |
|
|||||
|
2023
Q1 | $2.35M | Sell |
|
|||||
|
2022
Q4 | $3.96M | Buy |
|
|||||
|
2022
Q3 | $1.07M | Buy |
|
|||||
|
2022
Q2 | $289K | Buy |
|
|||||
|
2022
Q1 | $34K | Sell |
|
|||||
|
2021
Q4 | $1.31M | Sell |
|
|||||
|
2021
Q3 | $4.69M | Sell |
|
|||||
|
2021
Q2 | $8.89M | Sell |
|
|||||
|
2021
Q1 | $9.86M | Sell |
|
|||||
|
2020
Q4 | $17.5M | Buy |
|
|||||
|
2020
Q3 | $12.8M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $76K | Sell |
|
|||||
|
2018
Q1 | $188K | Sell |
|
|||||
|
2017
Q4 | $21.1M | Sell |
|
|||||
|
2017
Q3 | $45M | Sell |
|
|||||
|
2017
Q2 | $51.7M | Sell |
|
|||||
|
2017
Q1 | $49.3M | Buy |
|
|||||
|
2016
Q4 | $2.42M | Hold |
|
|||||
|
2016
Q3 | $2.91M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $39K | Sell |
|
|||||
|
2014
Q2 | $96K | Sell |
|
|||||
|
2014
Q1 | $203K | Buy |
|
|||||
|
2013
Q4 | $185K | Sell |
|
|||||
|
2013
Q3 | $182K | Buy |
|
|||||
|
2013
Q2 | $156K | Buy |
|